SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-019821
Filing Date
2023-05-09
Accepted
2023-05-09 16:56:05
Documents
61
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q crnx-20230331.htm   iXBRL 10-Q 2208662
2 EX-10.2 crnx-ex10_2.htm EX-10 39178
3 EX-31.1 crnx-ex31_1.htm EX-31 38177
4 EX-31.2 crnx-ex31_2.htm EX-31 38136
5 EX-32.1 crnx-ex32_1.htm EX-32 12049
  Complete submission text file 0000950170-23-019821.txt   9483361

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crnx-20230331.xsd EX-101.SCH 49689
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crnx-20230331_cal.xml EX-101.CAL 45973
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crnx-20230331_pre.xml EX-101.PRE 338807
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crnx-20230331_def.xml EX-101.DEF 198185
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crnx-20230331_lab.xml EX-101.LAB 461379
55 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20230331_htm.xml XML 2151753
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38583 | Film No.: 23903060
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences